scispace - formally typeset
G

Guido Kroemer

Researcher at Institut Gustave Roussy

Publications -  1546
Citations -  294816

Guido Kroemer is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Programmed cell death & Apoptosis. The author has an hindex of 236, co-authored 1404 publications receiving 246571 citations. Previous affiliations of Guido Kroemer include Karolinska Institutet & Spanish National Research Council.

Papers
More filters
Journal ArticleDOI

Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.

TL;DR: The phenotype, function and clinical significance of various Treg subsets are discussed, including FOXP3+ regulatory T cells, which accumulate within neoplastic lesions as a result of several distinct mechanisms, including increased infiltration, local expansion, survival advantage and in situ development from conventional CD4+ cells.
Journal ArticleDOI

Trial watch: Peptide-based vaccines in anticancer therapy.

TL;DR: Preclinical and clinical progress in the use of peptide-based vaccines as anticancer therapeutics is reviewed, with particular focus on personalized peptide vaccination.
Journal ArticleDOI

Immunogenicity of anthracyclines: moving towards more personalized medicine.

TL;DR: In this paper, the effects of anthracyclines on the host immune system and how this knowledge can be exploited for anticancer therapy are discussed. But, the authors do not discuss how to exploit this knowledge to improve the efficacy of chemotherapy.